Anxiety News

An hour-long telehealth session on mindfulness and compassion failed to achieve its primary outcome — decreased loneliness — but it did reduce depression, anxiety and perceived stress, research showed.

Routine screening for adverse childhood experiences and resilience may identify women at risk for developing depression or anxiety during pregnancy, according to a retrospective cohort study published in Obstetrics & Gynecology.

The FDA has granted breakthrough designation to MM-120 for the treatment of generalized anxiety disorder, according to a press release from MindMed.

Incannex Healthcare has announced positive topline results from its phase 2 PsiGAD1 clinical trial of psilocybin for generalized anxiety disorder, reporting statistically significant improvement in anxiety scores compared with placebo.

Quolet Industries has announced the completion of a phase 1 study evaluating a novel, lipid formulation of pure CBD as a potential treatment for various psychiatric and neurologic conditions.

Individuals with vision impairment have greater odds of experiencing symptoms of depression, anxiety and social isolation, according to new research published in JAMA Ophthalmology.

U.S. policy changes are needed to reduce perinatal mental health deserts, standardize social determinants of health data, improve psychiatric curriculums and establish paid parental leave, researchers reported in JAMA Psychiatry.

A woman in her late 50s is currently receiving treatment for her second bout of breast cancer. She is thought to be in remission, but Neelam Desai, MD, worries about more than just the disease.

Patients with diabetes on one of several GLP-1 receptor agonists were less likely to be diagnosed with depression and anxiety compared with those not on those medications, researchers found.

More than three-quarters of people with mild COVID-19 reported experiencing insomnia after recovery, and it was more common among those with anxiety or depression, according to the results of a survey.